PFE
28
2
HPQ
59
6
PGR
67
2
NWL
56
2
PPG
64
3
SRE
57
8
FLS
75
2
MDT
66
2
XRAY
46
2
CMG
69
-3
KLAC
57
4
HES
65
2
EBAY
44
-3
L
65
-3
OI
38
-4
CAG
36
2
FIS
46
-2
PSX
49
2
CCI
36
-2
HCP
62
2
PFE
28
2
HPQ
59
6
PGR
67
2
NWL
56
2
PPG
64
3
SRE
57
8
FLS
75
2
MDT
66
2
XRAY
46
2
CMG
69
-3
KLAC
57
4
HES
65
2
EBAY
44
-3
L
65
-3
OI
38
-4
CAG
36
2
FIS
46
-2
PSX
49
2
CCI
36
-2
HCP
62
2
Financhill
Back

Aurelius Equity Opportunities Se & Co KGaA Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
36

AULRF
Aurelius Equity Opportunities Se & Co KGaA

Last Price:
18.94
Seasonality Move:
-21.27%
Buy
58

SRPT
Sarepta Therapeutics

Last Price:
133.49
Seasonality Move:
14.88%
Sell
36
Aurelius Equity Opportunities Se & Co KGaA (AULRF) is a Sell

Is Aurelius Equity Opportunities Se & Co KGaA a Buy, Sell or Hold?

  • The current Aurelius Equity Opportunities Se & Co KGaA [AULRF] share price is $18.94. The Score for AULRF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • AULRF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AULRF Stock Price Chart

What is Aurelius Equity Opportunities Se & Co KGaA's stock price today?

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $133.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

AULRF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Sell
Relative Strength Index (14 RSI): 99.61 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.94 - 18.94) Sell
Bollinger Bands (100): (18.94 - 18.94) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 63.54 Buy
Chaikin Money Flow: -725343 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.85 - 129.81) Buy
Bollinger Bands (100): (119.21 - 141.67) Buy

AULRF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.94 Sell
20-day SMA: 18.94 Sell
50-day SMA: 18.94 Sell
200-day SMA: 18.94 Sell
8-day EMA: 18.94 Sell
20-day EMA: 18.94 Sell
50-day EMA: 18.94 Sell
200-day EMA: 18.99 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 119.83 Buy
20-day SMA: 118.14 Buy
50-day SMA: 122.33 Buy
200-day SMA: 130.09 Buy
8-day EMA: 123.82 Buy
20-day EMA: 120.48 Buy
50-day EMA: 122.96 Buy
200-day EMA: 126.17 Buy

Aurelius Equity Opportunities Se & Co KGaA Earnings Growth & AULRF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

Aurelius Equity Opportunities Se & Co KGaA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):